Literature DB >> 21175319

Therapeutic potential of oral factor Xa inhibitors.

Elaine M Hylek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21175319     DOI： 10.1056/NEJMe1012149

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Oral anticoagulant-associated intracerebral hemorrhage.

Authors:  Alvaro Cervera; Sergio Amaro; Angel Chamorro
Journal:  J Neurol       Date:  2011-07-05       Impact factor: 4.849

2.  Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease.

Authors:  Nishank Jain; Robert F Reilly
Journal:  Clin J Am Soc Nephrol       Date:  2018-05-25       Impact factor: 8.237

3.  Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol.

Authors:  Alicia Calderone; Wendy Stevens; David Prior; Harshal Nandurkar; Eli Gabbay; Susanna M Proudman; Trevor Williams; David Celermajer; Joanne Sahhar; Peter K K Wong; Vivek Thakkar; Nathan Dwyer; Jeremy Wrobel; Weng Chin; Danny Liew; Margaret Staples; Rachelle Buchbinder; Mandana Nikpour
Journal:  BMJ Open       Date:  2016-12-08       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.